Page results
-
This page explains the type of care we offer in the Supportive Care Unit at the University College Hospital Macmillan Cancer Centre.
-
Information about sickle cell disorder and pregnancy for UCLH patients.
-
This page aims to help you, your family or carers to plan ahead, and talk about decisions about your care or treatment that may need to be made in the future.
-
This page is designed for patients scheduled to attend our department. It outlines the various tests that may be conducted during your appointment.
-
This page is designed for patients scheduled to attend the Adult diagnostic audiology department. It outlines the various tests that may be conducted during your appointment.
-
UCLH provides a comprehensive service to diagnose, treat and support people with cancer. We are a specialist centre for many types of cancer and treat patients from both our local area and across the country.
-
This page is for women who use the UCLH maternity Hypertension service during pregnancy and the postnatal period.
-
The London Sarcoma Service is one of the largest sarcoma services in Europe with an international reputation for providing the highest quality of care to patients with sarcoma.
-
In partnership with Camden MSK, our department has agreed to provide ultrasound-guided joint and soft tissue injections to patients referred by the Camden community MSK services.
-
We provide a wide range of general paediatric services, led by a team of enthusiastic consultants and dedicated nurses.
File results
-
FOI/2024/0101 - Immunoglobulin drug treatments
-
FOI/2024/0108 - Clinical letters/ EPR, PAS, patient portal systems, hybrid mail contract
-
FOI/2024/0112 - Fertility treatment in 2021
-
FOI/2024/0116 - Patient treatment due to noise levels of the London Underground
-
FOI/2024/0121 - Migraine treatments
-
FOI/2024/0126 - Ophthalmology RTT pathway
-
FOI/2024/0128 - Post mortem cardiac device interrogation
-
FOI/2024/0129 - Nursing associate and anaesthesia associate staffing
-
FOI/2024/0131 - Alpha-1 Proteinase-Inhibitor (AAT) purchased in 2023
-
FOI/2024/0132 - Cancer patients diagnosed in A&E